In an opinion piece yesterday, the chair of the FDA advisory committee on Avandia recommended the agency change the way it evaluates experimental diabetes drugs.
Product news
July 10, 2007
4:00 am
Barr Pharmaceuticals said its subsidiary Barr Laboratories received FDA approval for its application to manufacture and market a generic version of Pharmacia and Upjohns Dostinex (cabergoline) tablets, 0.5 mg.
The FDA today approved the first generic versions of Novartis Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis).
Product news
June 19, 2007
4:00 am
Bradley Pharmaceuticals has announced the launch of Peranex HC Cream (hydrocortisone acetate 2% — lidocaine HCl 2%) by the Companys Kenwood Therapeutics division.
Product news
June 5, 2007
4:00 am
Critical Therapeutics said the FDA has approved the companys New Drug Application (NDA) for twice-daily Zyflo CR (zileuton) extended-release tablets.
Family Research Council file suit to overturn Plan B decision
The Family Research Council and a coalition of medical and women’s groups have filed suit to overturn the FDA’s decision to approve Plan B for OTC sales. They say the FDA lacked authority to approve the application and did so in response to political pressure.